Remove 2018 Remove Clinical Pharmacology Remove Pharmaceuticals Remove Regulations
article thumbnail

XPhyto Secures Exclusive Psychedelic Drug Development Agreement

The Pharma Data

On August 20, 2018, the Company signed the Exclusive Dealing Agreement with Prof. Löbenberg is a director of XPhyto and is the founder and director of the Drug Development and Innovation Centre, Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada. About XPhyto Therapeutics Corp.

article thumbnail

Janssen Presents Results from Phase 3 ACIS

The Pharma Data

Food and Drug Administration (FDA) approval for nmCRPC on February 14, 2018 and was approved for mCSPC on September 17, 2019. FDA on February 8, 2018. [vi] About the Janssen Pharmaceutical Companies of Johnson & Johnson. 2 ERLEADA ® received U.S. ERLEADA ® is taken orally, once daily, with or without food.

article thumbnail

Analysis Life Sciences Thank You The 53 regulations that FDA is currently working on

Agency IQ

The 53 regulations that FDA is currently working on The FDA on Friday unveiled its much-anticipated Spring 2024 Unified Agenda, a document outlining the regulations the agency plans to release in 2024 and beyond. Of those 53, seven are new to the Agenda, having never before been included in prior agendas.